🇺🇸 FDA

Intelligence · Clinical Pipeline

Pfizer Pipeline

All ClinicalTrials.gov programs at Pfizer — phase, modality, and trial IDs.

Programs
98

Quick answer

Pfizer has 98 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. gabapentin

    Pfizer

    Epilepsies, Partial

    phase 3 small molecule completed

    1 trial

  2. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 small molecule terminated

    1 trial

  3. olmesartan alone or in combination with hydrochlorothiazide

    Pfizer

    Essential Hypertension

    phase 3 small molecule completed

    1 trial

  4. pegaptanib sodium

    Pfizer

    Macular Degeneration

    phase 3 small molecule completed

    1 trial

  5. placebo

    Pfizer

    Schizophrenia

    phase 3 small molecule terminated

    1 trial

  6. pregabalin

    Pfizer

    Neuropathy

    phase 3 small molecule terminated

    1 trial

  7. pregabalin

    Pfizer

    Partial Seizures

    phase 3 small molecule completed

    2 trials

  8. sildenafil

    Pfizer

    Hypertension, Pulmonary

    phase 3 small molecule completed

    1 trial

  9. sunitinib malate

    Pfizer

    Carcinoma, Hepatocellular

    phase 3 small molecule terminated

    1 trial

  10. talazoparib plus enzalutamide

    Pfizer

    Prostate Cancer

    phase 3 small molecule active

    1 trial

  11. AG-013736

    Pfizer

    Thyroid Neoplasms

    phase 2 small molecule completed

    1 trial

  12. CE-326,597 100 mg QD

    Pfizer

    Weight Management

    phase 2 small molecule completed

    1 trial

  13. Maraviroc

    Pfizer

    Arthritis, Rheumatoid

    phase 2 small molecule terminated

    1 trial

  14. PD 0332991

    Pfizer

    Breast Cancer

    phase 2 small molecule completed

    1 trial

  15. PF-03446962

    Pfizer

    Carcinoma, Hepatocellular

    phase 2 small molecule terminated

    1 trial

  16. PF-04236921 SC injection

    Pfizer

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  17. PF-06650833

    Pfizer

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  18. PF-06835375

    Pfizer

    Primary Immune Thrombocytopenia

    phase 2 mab active

    1 trial

  19. PH-797804

    Pfizer

    Pulmonary Disease, Chronic Obstructive

    phase 2 small molecule completed

    1 trial

  20. Sasanlimab Prefilled syringe

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule terminated

    1 trial

  21. UK-453,061 Dose 1

    Pfizer

    HIV-1

    phase 2 small molecule terminated

    1 trial

  22. disitamab vedotin

    Pfizer

    Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  23. Artesunate (Test)

    Pfizer

    Falciparum Malaria

    phase 1 small molecule completed

    1 trial

  24. BEZ235 + MEK162

    Pfizer

    Unspecified Adult Solid Tumor, Protocol Specific

    phase 1 small molecule completed

    1 trial

  25. BMP-655/ACS+Standard of care or Standard of care

    Pfizer

    Rotator Cuff Tear

    phase 1 mab terminated

    1 trial

  26. PF-03715455

    Pfizer

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  27. PF-05190457

    Pfizer

    Diabetes Mellitus, Type 2

    phase 1 small molecule completed

    1 trial

  28. PF-07038124 or vehicle

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial

  29. Pf-04937319

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial

  30. Placebo

    Pfizer

    Respiratory Syncytial Virus Infections

    phase 1 small molecule terminated

    1 trial

  31. Sunitinib, Pemetrexed

    Pfizer

    Neoplasm, Malignant

    phase 1 small molecule completed

    1 trial

  32. Tasocitinib 10 mg oral tablet

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial

  33. Treatment A

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial

  34. Treatment A

    Pfizer

    Asthma

    phase 1 small molecule completed

    1 trial

  35. tofacitinib 10 mg

    Pfizer

    Healthy

    phase 1 small molecule completed

    1 trial

  36. Amlodipine besylate/atorvastatin calcium single pill combination

    Pfizer

    Hypertension

    approved small molecule completed

    1 trial

  37. Apixaban

    Pfizer

    Atrial Fibrillation

    approved small molecule completed

    1 trial

  38. Atorvastatin

    Pfizer

    Dyslipidemias

    approved small molecule completed

    1 trial

  39. Celecoxib

    Pfizer

    Arthritis, Juvenile Rheumatoid

    approved small molecule completed

    1 trial

  40. Etanercept

    Pfizer

    Moderate to Severe Psoriasis

    approved small molecule completed

    1 trial

  41. Pregabalin

    Pfizer

    Bone Neoplasms

    approved small molecule terminated

    1 trial

  42. Sildenafil citrate

    Pfizer

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    1 trial

  43. Tofacitinib with methotrexate

    Pfizer

    Rhematoid Arthritis

    approved small molecule completed

    1 trial

  44. Zavicefta, Ceftazidime-Avibactam

    Pfizer

    Hospital-Acquired Pneumonia

    approved small molecule completed

    1 trial

  45. dexmedetomidine

    Pfizer

    MRI Sedation

    approved small molecule completed

    1 trial

  46. inotuzumab ozogamicin-dose level 2

    Pfizer

    Leukemia

    approved small molecule completed

    1 trial

  47. pregabalin

    Pfizer

    Diabetic Neuropathy, Painful

    approved small molecule completed

    1 trial

  48. pregabalin and celecoxib

    Pfizer

    Chronic Low Back Pain With a Neuropathic Component

    approved small molecule terminated

    1 trial

Frequently asked questions

How many pipeline programs does Pfizer have?

98 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.